Outbreaks of mumps genotype G viruses in the Netherlands between October 2019 and March 2020: clusters associated with multiple introductions.
Genotype G viruses
MMR
Mumps
Surveillance
The Netherlands
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
04 Oct 2021
04 Oct 2021
Historique:
received:
11
12
2020
accepted:
10
09
2021
entrez:
5
10
2021
pubmed:
6
10
2021
medline:
7
10
2021
Statut:
epublish
Résumé
From October 2019-March 2020, several clusters of mumps cases were identified in the Netherlands. Our objective was to describe cluster-associated mumps virus transmission using epidemiological and molecular information in order to help future mumps outbreak investigation and control efforts. An epidemiological cluster includes ≥ 2 mumps cases with at least an epidemiological-link to a laboratory-confirmed mumps case. A molecular group includes ≥ 2 mumps cases with identical mumps virus sequences. Cases with symptom onset date between 1 October 2019 and 31 March 2020 reported through the National Notifiable Diseases Surveillance System were included. We described epidemiological and clinical characteristics of mumps cases. Sequence data was obtained from selected regions of mumps virus genomes (2270 nucleotides). Associations between epidemiological and molecular information were investigated. In total, 102 mumps cases were notified (90% laboratory-confirmed, 10% epidemiologically-linked). 71 out of 102 cases were identified as part of an epidemiological cluster and/or molecular group. Twenty-one (30%) of 71 cases were identified solely from epidemiological information, 25 (35%) solely from molecular surveillance, and 25 (35%) using both. Fourteen epidemiological clusters were identified containing a total of 46 (range: 2-12, median: 3) cases. Complete sequence data was obtained from 50 mumps genotype G viruses. Twelve molecular groups were identified containing 43 (range: 2-13) cases, dispersed geographically and timewise. Combined information grouped seven epidemiological clusters into two distinct molecular groups. The first lasting for 14 weeks, the other for 6. Additionally, one molecular group was detected, linked by geography and time but without an epidemiological-link. Combined epidemiological and molecular information indicated ongoing mumps virus transmission from multiple introductions for extended time periods. Sequence analysis provided valuable insights into epidemiological clustering. If combined information is available in a timely manner, this would improve outbreak detection, generate further insight into mumps transmission, and guide necessary control measures.
Sections du résumé
BACKGROUND
BACKGROUND
From October 2019-March 2020, several clusters of mumps cases were identified in the Netherlands. Our objective was to describe cluster-associated mumps virus transmission using epidemiological and molecular information in order to help future mumps outbreak investigation and control efforts.
METHODS
METHODS
An epidemiological cluster includes ≥ 2 mumps cases with at least an epidemiological-link to a laboratory-confirmed mumps case. A molecular group includes ≥ 2 mumps cases with identical mumps virus sequences. Cases with symptom onset date between 1 October 2019 and 31 March 2020 reported through the National Notifiable Diseases Surveillance System were included. We described epidemiological and clinical characteristics of mumps cases. Sequence data was obtained from selected regions of mumps virus genomes (2270 nucleotides). Associations between epidemiological and molecular information were investigated.
RESULTS
RESULTS
In total, 102 mumps cases were notified (90% laboratory-confirmed, 10% epidemiologically-linked). 71 out of 102 cases were identified as part of an epidemiological cluster and/or molecular group. Twenty-one (30%) of 71 cases were identified solely from epidemiological information, 25 (35%) solely from molecular surveillance, and 25 (35%) using both. Fourteen epidemiological clusters were identified containing a total of 46 (range: 2-12, median: 3) cases. Complete sequence data was obtained from 50 mumps genotype G viruses. Twelve molecular groups were identified containing 43 (range: 2-13) cases, dispersed geographically and timewise. Combined information grouped seven epidemiological clusters into two distinct molecular groups. The first lasting for 14 weeks, the other for 6. Additionally, one molecular group was detected, linked by geography and time but without an epidemiological-link.
CONCLUSIONS
CONCLUSIONS
Combined epidemiological and molecular information indicated ongoing mumps virus transmission from multiple introductions for extended time periods. Sequence analysis provided valuable insights into epidemiological clustering. If combined information is available in a timely manner, this would improve outbreak detection, generate further insight into mumps transmission, and guide necessary control measures.
Identifiants
pubmed: 34607555
doi: 10.1186/s12879-021-06702-7
pii: 10.1186/s12879-021-06702-7
pmc: PMC8488918
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1035Informations de copyright
© 2021. The Author(s).
Références
Euro Surveill. 2010 Apr 29;15(17):
pubmed: 20460086
Infect Genet Evol. 2021 Jul;91:104794
pubmed: 33662587
Vaccine. 2012 Apr 19;30(19):2999-3002
pubmed: 22381073
BMC Infect Dis. 2017 Jan 10;17(1):56
pubmed: 28068914
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
Mol Biol Evol. 2013 Mar;30(3):713-24
pubmed: 23180580
PLoS One. 2020 Sep 14;15(9):e0233143
pubmed: 32925979
J Med Virol. 2005 Mar;75(3):470-4
pubmed: 15648065
Mol Biol Evol. 2013 May;30(5):1188-95
pubmed: 23418397
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Epidemiol Infect. 2003 Aug;131(1):703-9
pubmed: 12948370
Euro Surveill. 2019 Mar;24(12):
pubmed: 30914076
Vaccine. 2010 Apr 9;28(17):2932-6
pubmed: 20188683
Infect Genet Evol. 2016 Nov;45:145-150
pubmed: 27590714
Elife. 2021 Apr 19;10:
pubmed: 33871357
PLoS Biol. 2020 Feb 11;18(2):e3000611
pubmed: 32045407
Vaccine. 2019 Mar 22;37(13):1775-1784
pubmed: 30797639
Vaccine. 2012 Jun 29;30(31):4676-80
pubmed: 22579874
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
Sci Rep. 2019 Aug 30;9(1):12615
pubmed: 31471545
J Mol Evol. 2002 Feb;54(2):156-65
pubmed: 11821909
Lancet. 2008 Mar 15;371(9616):932-44
pubmed: 18342688
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Infect Genet Evol. 2019 Apr;69:230-234
pubmed: 30738791
Euro Surveill. 2018 Apr;23(15):
pubmed: 29667574
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904